Bridgewater Associates, LP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1350694
Westport, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,396,971
-$567,463 QoQ
Shares Held
10,865
-18.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#463
of 1,735 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $347,338,125 across 26 Biotechnology names. VRTX ranks #14 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
455,392 | $48,553,895 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
463,146 | $36,250,437 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
448,143 | $33,377,690 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,333 | $32,008,178 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
99,584 | $29,977,771 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
429,904 | $23,618,925 | |
| 7 | EXEL |
Exelixis, Inc.
|
400,859 | $21,810,738 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
54,489 | $20,251,926 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,396,971 | 10,865 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,964,434 | 13,357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,461,959 | 27,488 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,009,211 | 38,324 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,310,428 | 34,390 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $285,917 | 710 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,605,456 | 3,452 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,575,096 | 33,229 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $56,303,856 | 134,695 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $53,853,519 | 132,354 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $55,064,281 | 158,349 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $62,046,307 | 176,313 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $64,361,239 | 204,276 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,114,510 | 100,819 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $47,481,954 | 163,991 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $61,191,262 | 217,152 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,868,767 | 30,152 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,726,773 | 12,417 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,742,072 | 15,117 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,689,107 | 23,256 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,660,749 | 21,689 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $857,914 | 3,630 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||